Expression analysis of Rho GTPase-related lncRNAs in breast cancer

The Rho GTPases have prominent roles in cell cycle transition and cell migration. Some members of this family have been found to be mutated in cancers. Moreover, alterations in expression levels and/or activity of these proteins have been reported in many types of cancers. Thus, Rho GTPases are invo...

Full description

Saved in:
Bibliographic Details
Published in:Pathology, research and practice research and practice, 2023-04, Vol.244, p.154429-154429, Article 154429
Main Authors: Nicknam, Amir, Khojasteh Pour, Sahar, Hashemnejad, Mohammad Amin, Hussen, Bashdar Mahmud, Safarzadeh, Arash, Eslami, Solat, Taheri, Mohammad, Ghafouri-Fard, Soudeh, Jamali, Elena
Format: Article
Language:English
Subjects:
Breast cancer
Breast Neoplasms - genetics
Breast Neoplasms - pathology
Carcinogenesis - genetics
Cell Line, Tumor
DANCR
Female
Gene Expression Regulation, Neoplastic - genetics
Humans
LncRNA
MicroRNAs - genetics
NORAD
NRAV
RAD51-AS1
rho GTP-Binding Proteins - genetics
rho GTP-Binding Proteins - metabolism
Rho GTPase
RNA, Long Noncoding - genetics
RNA, Long Noncoding - metabolism
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Rho GTPases have prominent roles in cell cycle transition and cell migration. Some members of this family have been found to be mutated in cancers. Moreover, alterations in expression levels and/or activity of these proteins have been reported in many types of cancers. Thus, Rho GTPases are involved in the carcinogenesis. Rho GTPases regulate growth, motility, invasiveness and metastatic ability of breast cancer cells. Long non-coding RNAs (lncRNAs) have been revealed to exert significant effect in the regulation of these proteins via direct routes or through sequestering microRNAs that inhibit Rho GTPases. We aimed to assess expression levels of four Rho GTPase-related lncRNAs, namely NORAD, RAD51-AS1, NRAV and DANCR in breast cancer samples versus non-cancerous specimens from the same individuals. Expression levels of NORAD were shown to be elevated in tumoral tissues compared with non-tumoral tissues (Expression ratio (95% CI)= 5.85 (3.16–10.83), Standard error of mean (SEM)= 0.44, P value
ISSN:0344-0338
1618-0631
DOI:10.1016/j.prp.2023.154429